Profilo
Donald Handley worked as a Director of Global Regulatory Affairs at Bausch & Lomb, Inc. and as a Director of Regulatory Affairs at Cleveland BioLabs, Inc. Prior to that, he was a Manager of Worldwide Regulatory Affairs at Bristol Myers Squibb Co. and a Senior Manager of Regulatory Affairs at Celltech Medeva.
He received his undergraduate and graduate degrees from The State University of New York and also holds an MBA.
Precedenti posizioni note di Donald Handley
Società | Posizione | Fine |
---|---|---|
Celltech Medeva /Anesthetic Business/ | Consigliere Generale | 01/01/2002 |
BRISTOL-MYERS SQUIBB COMPANY | Consigliere Generale | 01/01/1999 |
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Consigliere Generale | - |
STATERA BIOPHARMA, INC. | Consigliere Generale | - |
Formazione di Donald Handley
The State University of New York | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Aziende private | 3 |
---|---|
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Health Technology |
Cleveland BioLabs, Inc.
Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY. | Health Technology |
Celltech Medeva /Anesthetic Business/ | Health Technology |
- Borsa valori
- Insiders
- Donald Handley